首页> 外文期刊>The Journal of toxicological sciences >Predicting the results of a 24-hr human patch test for surfactants: utility of margin-setting in a reconstructed human epidermis model
【24h】

Predicting the results of a 24-hr human patch test for surfactants: utility of margin-setting in a reconstructed human epidermis model

机译:预测表面活性剂24-HR人贴剂试验的结果:重建人表皮模型中边缘设置的效用

获取原文
获取原文并翻译 | 示例
           

摘要

To predict the results of a 24-hr closed human patch test, we previously recommended the use of in vitro test with a reconstructed human epidermis (RhE) model adopted in OECD TG 439, and proposed the margin method, which includes evaluation of twice the concentration to avoid a false positive for surfactants. Therefore, in this study, we used LabCyte EPI-MODEL as a RhE model, and confirmed the reproducibility of this method using five surfactants, including benzalkonium chloride (BC), sodium lauryl sulfate (SLS), and lauryl betaine (LB), for which false negative results have previously been reported, and three different surfactants. For all surfactants, prediction of patch test results using a margin of two revealed that human tests could be performed safely, confirming the utility of the margin method. In addition, we examined the relationship with critical micellar concentration (CMC). The IC50 for cell viability in the RhE model for three types of surfactants (BC, SLS, and LB) was 2.7- to 49.7-times the CMC. Therefore, the range of concentrations in which tests were performed with the present method was within the range of concentrations with high cleansing. Furthermore, we examined the relationship between cell viability and release of the inflammatory mediator interleukin-1 alpha (1L-1 alpha). IL-1 alpha release was associated with cell viability, supporting the results of the human patch test.
机译:为了预测24小时封闭的人贴剂测试,我们之前建议使用在经合组织TG 439中采用的重建人表皮(RHE)模型的体外试验,并提出了包括两倍的评估方法浓缩以避免表面活性剂的假阳性。因此,在本研究中,我们使用Labcyte Epi-Model作为RHE模型,并确认了使用五种表面活性剂的方法的再现性,包括苄氯化铵(BC),十二烷基硫酸钠(SLS)和月桂醇(LB),用于先前已经报道了哪种假阴性结果和三种不同的表面活性剂。对于所有表面活性剂,使用两个边缘的贴片试验结果的预测显示,可以安全地进行人体测试,确认裕度方法的效用。此外,我们检查了临界胶束浓度(CMC)的关系。用于三种类型表面活性剂(BC,SLS和LB)的RHE模型中的用于细胞活力的IC50为CMC 2.7-至49.7倍。因此,用本方法进行试验的浓度范围在具有高清洁的浓度范围内。此外,我们检查了细胞活力与炎症介质白细胞介素-1α(1L-1α)的释放之间的关系。 IL-1α释放与细胞活力相关,支持人类贴剂测试的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号